TY - JOUR
T1 - Positionspapier der ÖGR und ÖGP zur Diagnose und Therapie der Sarkoidose 2024
AU - Sterniste, Georg
AU - Hackner, Klaus
AU - Moazedi-Fürst, Florentine
AU - Grasl, Marie
AU - Izdko, Marco
AU - Shao, Guangyu
AU - Guttmann-Ducke, Claudia
AU - Talakić, Emina
AU - Prosch, Helmut
AU - Lohfink-Schumm, Sylvia
AU - Gabriel, Michael
AU - Lim, Clarice
AU - Hochreiter, Johann
AU - Bucher, Brigitte
AU - Böckle, Barbara C
AU - Kiener, Hans Peter
AU - Duftner, Christina
AU - Kastrati, Kastriot
AU - Rath, Eva
AU - Funk, Marion
AU - Löffler-Ragg, Judith
AU - Steinmaurer, Monika
AU - Kovacs, Gabor
AU - Verheyen, Nicolas
AU - Flick, Holger
AU - Antlanger, Marlies
AU - Traxler, Gerhard
AU - Tatscher, Elisabeth
AU - Zwick, Ralf Harun
AU - Lang, David
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/10
Y1 - 2024/10
N2 - In many cases sarcoidosis is a multisystemic disease that requires interdisciplinary medical cooperation in the diagnostics, treatment and medical care during follow-up. Due to the often chronic course, it is of utmost importance to include patients with their priorities and wishes at an early stage and extensively in disease management and to establish a shared decision making whenever possible. In the process of writing this joint position paper, the expert group on interstitial and orphan lung diseases of the Austrian Society for Pulmonology and the working group on rheumatological lung disorders of the Austrian Society for Rheumatology and Rehabilitation sought to include patient advocacy groups as well as experts for rare organ manifestations of sarcoidosis. This position paper is not only meant to reflect current scientific and clinical standards but should also focus the national expertise and by networking and exchange to be a first step to strengthen cooperation between stakeholders to ultimately improve care for patients with sarcoidosis.
AB - In many cases sarcoidosis is a multisystemic disease that requires interdisciplinary medical cooperation in the diagnostics, treatment and medical care during follow-up. Due to the often chronic course, it is of utmost importance to include patients with their priorities and wishes at an early stage and extensively in disease management and to establish a shared decision making whenever possible. In the process of writing this joint position paper, the expert group on interstitial and orphan lung diseases of the Austrian Society for Pulmonology and the working group on rheumatological lung disorders of the Austrian Society for Rheumatology and Rehabilitation sought to include patient advocacy groups as well as experts for rare organ manifestations of sarcoidosis. This position paper is not only meant to reflect current scientific and clinical standards but should also focus the national expertise and by networking and exchange to be a first step to strengthen cooperation between stakeholders to ultimately improve care for patients with sarcoidosis.
KW - Austria
KW - Humans
KW - Rheumatology/standards
KW - Pulmonary Medicine/standards
KW - Sarcoidosis/therapy
KW - Practice Guidelines as Topic
KW - Sarcoidosis, Pulmonary/therapy
KW - Societies, Medical
KW - Evidence-Based Medicine
UR - http://www.scopus.com/inward/record.url?scp=85206031989&partnerID=8YFLogxK
U2 - 10.1007/s00508-024-02444-z
DO - 10.1007/s00508-024-02444-z
M3 - Artikel in Fachzeitschrift
C2 - 39382646
SN - 1613-7671
VL - 136
SP - 669
EP - 687
JO - Wiener Klinische Wochenschrift. The Central European Journal of Medicine
JF - Wiener Klinische Wochenschrift. The Central European Journal of Medicine
IS - Suppl 17
ER -